Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon
Pediatric Blood & Cancer, 04/27/2012
Chiu YE et al. – The authors report 11 patients treated with propranolol for kaposiform hemangioendothelioma (KHE) and the related variant tufted angioma (TA), six of whom also had Kasabach–Merritt phenomenon (KMP). The varied responses to treatment, with only 36% responding in series, demonstrate the need for further study of this medication before routine use for these indications.